Deltalab takes a majority stakeholder position in the capital of the company Nirco
Deltalab will participate in Labclin 2013, the VII National Clinical Laboratory Congress, which is unveiled in Bilbao from October 23 to 25, and considers the largest national hospitality in the sector.
Nirco is part of Deltalab Group
Nirco integrant of the Business Group
Nirco as a member of the Deltalab business group, focuses the seva activitat in the manufacture and marketing of products and services adreçats à l’àmbit de les Ciències de la Salut.
The Division of Biomedical Research
Comercialitza instrumentació, reactius and specific consumables to the laboratory of human and veterinary research, oferint complete solutions to the necessities of the researcher.
The Qualitat Control Division
We offer a wide gamma of products and services destined to the control of industrial processes, especially in the sectors of control of qualitat agroalimentari, laboratory of production and animal health or the pharmaceutical and cosmetic industry.
The Division of Regenerative Medicine
Innovative solutions, technologically advanced for the process and preservation of cèl·lules mare in hospital beds and hospital centers involved in the application and research of cell therapies related to regenerative medicine.
An organization in constant evolution, formed by professionals highly qualificats in totes les àrees d’activitat of the company, provides a direct, proper, flexible and personal service to guarantee the clients the integral solution to the special needs of the individuals.
Deltalab and NTE-Sener will share a stand at the exhibition area of the Palau de Congresos Euskalduna in Bilbao. There it will show the nova gamma d’escovillons amb medi liquid Deltaswab, unwrapped by Deltalab, jointly with the AUTOPLAK device, which will be marketed jointly. AUTOPLAK has been developed by NTE-Sener and is a machine that automates the inoculation and seeding of plaques in microbiology laboratories. Together with the Deltaswab gamma, they contribute to increase the productivity of the laboratoris, with a notable reduction in the costs deriving from the process and the temps in the diagnosis.
Labclin 2013 is organized by the Spanish Association of Medical Biopathology (AEBM), the Spanish Association of Pharmaceutical Analysts (AEFA) and the Spanish Society of Clinical Biochemistry and Molecular Pathology (SEQC).